Peer-influenced content. Sources you trust. No registration required. This is HCN.
Northwestern Medicine
Early intervention in psychosis significantly improves outcomes, highlighting the necessity for holistic, patient-centered care.
Psychiatry June 4th 2024
In cases of prostate cancer post-aquablation therapy, managing residual tissue and persistent PSA levels poses significant challenges for surgical intervention, as detailed by Dr. Edward M. Schaeffer.
Oncology, Medical May 6th 2024
Johns Hopkins Medicine
Johns Hopkins psychiatrists are spearheading a novel educational initiative, ADAP Jr. High, to address the critical gap in middle schoolers’ understanding of anxiety and depression, offering structured lessons and coping strategies to empower young students.
Family Medicine/General Practice March 12th 2024
A recent study underscores the delicate balance required in thyroid hormone therapy for older adults, highlighting a clear association between thyrotoxicosis and heightened cognitive disorder risk.
Clinical Pharmacology March 12th 2024
The Johns Hopkins Clozapine Consultation Clinic is addressing the critical underutilization of clozapine in treatment-resistant schizophrenia, providing essential support and education for healthcare providers in navigating its benefits and risks.
Neurology March 12th 2024
Dana-Farber Cancer Institute
Under Dr. Laurie Glimcher’s leadership, Dana-Farber Cancer Institute is embarking on a transformative journey with the creation of a new, dedicated cancer hospital, promising a future of specialized care and improved patient experiences in oncology.
Hematology/Oncology March 11th 2024